Unlock instant, AI-driven research and patent intelligence for your innovation.

tmem16a as a marker of osteoporosis and its application, osteoporosis diagnostic kit and medicine

A diagnostic kit and osteoporosis technology, applied in the field of disease markers, can solve the problems of inability to compare with the true value, inaccurate judgment, and high measurement cost

Active Publication Date: 2021-05-07
HEBEI UNIV OF TECH
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The existing methods for diagnosing osteoporosis mainly have the following disadvantages: 1. The doctor's inquiry of past medical history can only provide reference, and cannot accurately determine whether he has osteoporosis
2. Bone mass measurement is a commonly used method nowadays, but whether a fracture occurs is mainly determined by bone strength, and bone strength is composed of many aspects such as bone mass, bone quality, bone composition, and bone shape. Quantitative judgment is not accurate enough
3. The result of ultrasonic measurement is not bone density or bone mineral content, which cannot be compared with the real value, and requires more observation data. In addition, the ultrasonic equipment is huge and inconvenient to move, and the cost of each measurement is high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • tmem16a as a marker of osteoporosis and its application, osteoporosis diagnostic kit and medicine
  • tmem16a as a marker of osteoporosis and its application, osteoporosis diagnostic kit and medicine
  • tmem16a as a marker of osteoporosis and its application, osteoporosis diagnostic kit and medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] In this example, the expression of TMEM16A in osteoclasts of patients with osteoporosis and normal people was measured, and a small amount of bone tissue was extracted from patients with osteoporosis through minimally invasive surgery, and primary osteoclasts were isolated from them, using complete medium (DMEM-α medium: fetal bovine serum = 9: 1) for cell culture. Through PCR experiment, analyze the change of TMEM16A RNA content in osteoclasts of osteoporosis patients compared with normal people. Using TMEM16A antibody to carry out cell immunoblotting experiments, comparative analysis of TMEM16A expression in osteoclasts from patients with osteoporosis and changes in normal expression. The result is as figure 1 As shown, it was found that the expression of TMEM16A in the bone tissue of osteoporosis patients was about 1.5 times higher than that of normal people, so the increased expression of TMEM16A is a marker of osteoporosis.

Embodiment 2

[0053] In this implementation, a mouse model of osteoporosis was first established, and then the content of TMEM16A in bone tissue of osteoporotic mice was measured.

[0054] The establishment method of the mouse osteoporosis model: select female C57 mice aged 3-6 months, and artificially remove the ovaries of the female mice through surgery, and culture them normally for four weeks to build a model, simulating the osteoporosis caused by estrogen deficiency in postmenopausal women. The male mice were male C57 mice aged 2-4 months. The testicles of female mice were artificially removed by surgery, and they were cultured normally for four weeks to build a model, simulating the senile osteoarthritis caused by the sharp decrease in the secretion of androgen in elderly men. mass porosis.

[0055] The measurement methods for the expression of TMEM16A mainly include: measuring the change of RNA content of TMEM16A by PCR, mainly including: extraction of total RNA by Trizol method, rev...

Embodiment 3

[0058]In this example, osteoclasts were induced to differentiate in vitro. The osteoclast induction and differentiation method was as follows: bone marrow cells were extracted from the bone marrow of C57 mice at 6-8 weeks, and the erythrocyte lysate was fully lysed and then centrifuged to extract bone marrow stromal cells. Add 10ng / After 24 hours, the supernatant was taken out, centrifuged at 1500rpm, and the culture medium containing 50ng / ml Rankl and 30ng / ml M-CSF was added to continue to cultivate for 5 days, during which the medium was replaced once, and it was used after 5 days TRAP staining kit was used to detect whether osteoclasts were successfully induced. The expression level of TMEM16A was detected by PCR and immunoblotting experimental methods, and the experimental methods were the same as those in the above-mentioned examples.

[0059] Then detect the content of TMEM16A in the cells after normal induction 1, 3 and 5 days respectively, the results are as follows: ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides TMEM16A as a marker of osteoporosis and its application, a diagnostic kit for osteoporosis and medicine, and relates to the technical field of disease markers. The osteoporosis diagnostic kit using TMEM16A as a marker of osteoporosis judges whether the subject suffers from osteoporosis by detecting the content of TMEM16A in the peripheral blood mononuclear cells of the subject. The diagnosis is fast and accurate, the operation is simple, and no special instruments and equipment are required. The drug for treating osteoporosis uses TMEM16A as a target, and regulates the expression level of TMEM16A in patients to alleviate the patients' osteoporosis.

Description

technical field [0001] The invention relates to the technical field of disease markers, in particular to TMEM16A as a marker of osteoporosis and its application, a diagnostic kit for osteoporosis and a medicine. Background technique [0002] Osteoporosis is a systemic bone metabolic disease characterized by decreased bone mass and changes in bone microstructure, accompanied by decreased bone strength, increased bone fragility, and increased risk of fracture. According to epidemiological statistics, the prevalence rate of osteoporosis among the population over 50 years old in my country is 20.7% for women and 14.4% for men. And according to the global epidemiological survey, the prevalence of osteoporosis in all countries is relatively high. The incidence of osteoporosis is related to many factors, among which gender factor and age factor have the greatest correlation with the occurrence of osteoporosis. The pain and fractures caused by osteoporosis seriously affect the qua...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68A61K31/7105A61P19/10
CPCA61K31/7105A61P19/10G01N33/6893
Inventor 安海龙李英贤陈娅斐凌树宽郭帅孙维佳王徐朝展永
Owner HEBEI UNIV OF TECH